Go Pro
→ The end may be near for these iconic stocks (From Chaikin Analytics) (Ad)tc pixel Free AFIB Stock Alerts

Acutus Medical (AFIB) Competitors

Acutus Medical logo
$0.0001 0.00 (-50.00%)
As of 08/14/2026 11:08 AM Eastern
Compare

AFIB vs. TTOO, UTRS, MOTS, DRTSW, and BDMDW

Should you buy Acutus Medical stock or one of its competitors? Acutus Medical's main competitors and comparable companies include T2 Biosystems (TTOO), Minerva Surgical (UTRS), Motus GI (MOTS), Alpha Tau Medical (DRTSW), and Baird Medical Investment (BDMDW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Acutus Medical compare to T2 Biosystems?

Acutus Medical (NASDAQ:AFIB) and T2 Biosystems (NASDAQ:TTOO) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, institutional ownership, earnings, profitability, valuation and risk.

56.9% of Acutus Medical shares are owned by institutional investors. Comparatively, 23.2% of T2 Biosystems shares are owned by institutional investors. 5.2% of Acutus Medical shares are owned by insiders. Comparatively, 0.0% of T2 Biosystems shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Acutus Medical has a beta of 5.7, indicating that its stock price is 470% more volatile than the broader market. Comparatively, T2 Biosystems has a beta of 7.75, indicating that its stock price is 675% more volatile than the broader market.

In the previous week, Acutus Medical's average media sentiment score of 0.00 equaled T2 Biosystems'average media sentiment score.

Company Overall Sentiment
Acutus Medical Neutral
T2 Biosystems Neutral

T2 Biosystems has higher revenue and earnings than Acutus Medical. Acutus Medical is trading at a lower price-to-earnings ratio than T2 Biosystems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Acutus Medical$7.16M0.00-$81.66M-$0.11N/A
T2 Biosystems$7.68M0.00-$50.08M-$3.89N/A

Acutus Medical has a net margin of -272.74% compared to T2 Biosystems' net margin of -563.16%. T2 Biosystems' return on equity of 0.00% beat Acutus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Acutus Medical-272.74% -311.64% -11.57%
T2 Biosystems -563.16%N/A -174.06%

Summary

T2 Biosystems beats Acutus Medical on 6 of the 11 factors compared between the two stocks.

How does Acutus Medical compare to Minerva Surgical?

Acutus Medical (NASDAQ:AFIB) and Minerva Surgical (NASDAQ:UTRS) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends.

Minerva Surgical has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. Minerva Surgical's return on equity of 0.00% beat Acutus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Acutus Medical-272.74% -311.64% -11.57%
Minerva Surgical N/A N/A N/A

56.9% of Acutus Medical shares are held by institutional investors. 5.2% of Acutus Medical shares are held by company insiders. Comparatively, 8.5% of Minerva Surgical shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Minerva Surgical has higher revenue and earnings than Acutus Medical. Acutus Medical is trading at a lower price-to-earnings ratio than Minerva Surgical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Acutus Medical$7.16M0.00-$81.66M-$0.11N/A
Minerva Surgical$51.69M0.00-$34.11M-$1.81N/A

In the previous week, Acutus Medical's average media sentiment score of 0.00 equaled Minerva Surgical'saverage media sentiment score.

Company Overall Sentiment
Acutus Medical Neutral
Minerva Surgical Neutral

Acutus Medical has a beta of 5.7, indicating that its share price is 470% more volatile than the broader market. Comparatively, Minerva Surgical has a beta of 2.41, indicating that its share price is 141% more volatile than the broader market.

Summary

Minerva Surgical beats Acutus Medical on 7 of the 10 factors compared between the two stocks.

How does Acutus Medical compare to Motus GI?

Motus GI (NASDAQ:MOTS) and Acutus Medical (NASDAQ:AFIB) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, risk, analyst recommendations, earnings, dividends, media sentiment, profitability and institutional ownership.

20.1% of Motus GI shares are held by institutional investors. Comparatively, 56.9% of Acutus Medical shares are held by institutional investors. 0.3% of Motus GI shares are held by insiders. Comparatively, 5.2% of Acutus Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Motus GI has higher earnings, but lower revenue than Acutus Medical. Acutus Medical is trading at a lower price-to-earnings ratio than Motus GI, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Motus GI$319K0.00-$12.87M-$14.69N/A
Acutus Medical$7.16M0.00-$81.66M-$0.11N/A

In the previous week, Motus GI's average media sentiment score of 0.00 equaled Acutus Medical'saverage media sentiment score.

Company Overall Sentiment
Motus GI Neutral
Acutus Medical Neutral

Motus GI has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. Motus GI's return on equity of 0.00% beat Acutus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Motus GIN/A N/A N/A
Acutus Medical -272.74%-311.64%-11.57%

Motus GI has a beta of 0.79, meaning that its stock price is 21% less volatile than the broader market. Comparatively, Acutus Medical has a beta of 5.7, meaning that its stock price is 470% more volatile than the broader market.

Summary

Motus GI and Acutus Medical tied by winning 5 of the 10 factors compared between the two stocks.

How does Acutus Medical compare to Alpha Tau Medical?

Acutus Medical (NASDAQ:AFIB) and Alpha Tau Medical (NASDAQ:DRTSW) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, dividends, earnings, institutional ownership, analyst recommendations, media sentiment and risk.

Alpha Tau Medical has lower revenue, but higher earnings than Acutus Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Acutus Medical$7.16M0.00-$81.66M-$0.11N/A
Alpha Tau MedicalN/AN/AN/AN/AN/A

In the previous week, Alpha Tau Medical had 3 more articles in the media than Acutus Medical. MarketBeat recorded 3 mentions for Alpha Tau Medical and 0 mentions for Acutus Medical. Alpha Tau Medical's average media sentiment score of 0.62 beat Acutus Medical's score of 0.00 indicating that Alpha Tau Medical is being referred to more favorably in the news media.

Company Overall Sentiment
Acutus Medical Neutral
Alpha Tau Medical Positive

Alpha Tau Medical has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. Alpha Tau Medical's return on equity of 0.00% beat Acutus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Acutus Medical-272.74% -311.64% -11.57%
Alpha Tau Medical N/A N/A N/A

56.9% of Acutus Medical shares are held by institutional investors. 5.2% of Acutus Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Alpha Tau Medical beats Acutus Medical on 5 of the 8 factors compared between the two stocks.

How does Acutus Medical compare to Baird Medical Investment?

Baird Medical Investment (NASDAQ:BDMDW) and Acutus Medical (NASDAQ:AFIB) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, institutional ownership, dividends, earnings, analyst recommendations, media sentiment and profitability.

56.9% of Acutus Medical shares are held by institutional investors. 5.2% of Acutus Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Baird Medical Investment has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. Baird Medical Investment's return on equity of 0.00% beat Acutus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Baird Medical InvestmentN/A N/A N/A
Acutus Medical -272.74%-311.64%-11.57%

Baird Medical Investment has higher revenue and earnings than Acutus Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Baird Medical Investment$22.54MN/AN/AN/AN/A
Acutus Medical$7.16M0.00-$81.66M-$0.11N/A

In the previous week, Baird Medical Investment had 2 more articles in the media than Acutus Medical. MarketBeat recorded 2 mentions for Baird Medical Investment and 0 mentions for Acutus Medical. Baird Medical Investment's average media sentiment score of 0.43 beat Acutus Medical's score of 0.00 indicating that Baird Medical Investment is being referred to more favorably in the media.

Company Overall Sentiment
Baird Medical Investment Neutral
Acutus Medical Neutral

Summary

Baird Medical Investment beats Acutus Medical on 6 of the 8 factors compared between the two stocks.

Get Acutus Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for AFIB and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AFIB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AFIB vs. The Competition

Export
MetricAcutus MedicalHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$3K$5.83B$7.00B$13.04B
Dividend YieldN/A1.75%2.56%10.42%
P/E Ratio0.0026.59271.5525.35
Price / Sales0.0063.13603.37100.47
Price / CashN/A33.8328.8738.43
Price / Book0.006.1011.176.52
Net Income-$81.66M$148.46M$3.45B$346.81M
7 Day PerformanceN/A1.24%0.98%1.27%
1 Month PerformanceN/A4.77%2.30%2.57%
1 Year PerformanceN/A9.03%62.38%20.83%

Acutus Medical Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AFIB
Acutus Medical
N/A$0.00
-50.0%		N/A-80.0%$3K$7.16MN/A340
TTOO
T2 Biosystems
N/A$0.00
flat		N/A-95.5%$11K$7.68MN/A180
UTRS
Minerva Surgical
N/AN/AN/AN/A$1K$51.69MN/A160
MOTS
Motus GI
N/AN/AN/AN/A$1K$319KN/A30
DRTSW
Alpha Tau Medical
N/A$3.58
+6.4%		N/A+1,300.7%$0.00N/AN/A80

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:AFIB) was last updated on 8/17/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel